FAKTOR-OPTIONSSCHEIN - BIOGEN IDEC | Delayed Deutsche Boerse AG 04:56:31 10/05/2024 pm IST | ||
| 0.14 EUR | 0.00% |
|
| Current month | +16.67% | ||
| 1 month | +40.00% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/24/10 | 0.14 | 0.00% | 0 |
| 09/24/09 | 0.14 | +7.69% | 0 |
| 08/24/08 | 0.13 | +8.33% | 0 |
| 07/24/07 | 0.12 | -7.69% | 0 |
| 06/24/06 | 0.13 | +8.33% | 0 |
Delayed Quote Deutsche Boerse AG
Last update May 10, 2024 at 04:56 pm IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SH0DQ3 |
| ISIN | DE000SH0DQ33 |
| Date issued | 07/12/2021 |
| Strike | 223.6 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10.02 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 16.23 € |
|---|---|
| Lowest since issue | 0.055 € |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
222.8
USD
Average target price
285.9
USD
Spread / Average Target
+28.36%
- Stock Market
- Certificates
- Certificat